chr15-42144000-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000397272.7(PLA2G4F):āc.2120A>Gā(p.Tyr707Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,610,344 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.000034 ( 0 hom. )
Consequence
PLA2G4F
ENST00000397272.7 missense
ENST00000397272.7 missense
Scores
9
8
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
PLA2G4F (HGNC:27396): (phospholipase A2 group IVF) Predicted to enable calcium ion binding activity; calcium-dependent phospholipase A2 activity; and calcium-dependent phospholipid binding activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within several processes, including arachidonic acid secretion; cellular response to antibiotic; and prostaglandin biosynthetic process. Predicted to be located in cytoplasm. Predicted to be active in cytosol; ruffle membrane; and vesicle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLA2G4F | NM_213600.4 | c.2120A>G | p.Tyr707Cys | missense_variant | 18/20 | ENST00000397272.7 | NP_998765.3 | |
PLA2G4F | NR_033151.2 | n.2134A>G | non_coding_transcript_exon_variant | 17/19 | ||||
PLA2G4F | XR_931785.1 | n.2207A>G | non_coding_transcript_exon_variant | 18/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLA2G4F | ENST00000397272.7 | c.2120A>G | p.Tyr707Cys | missense_variant | 18/20 | 1 | NM_213600.4 | ENSP00000380442 | P1 | |
PLA2G4F | ENST00000290497.11 | c.*1864A>G | 3_prime_UTR_variant, NMD_transcript_variant | 17/19 | 1 | ENSP00000290497 | ||||
PLA2G4F | ENST00000562320.1 | c.208+450A>G | intron_variant, NMD_transcript_variant | 1 | ENSP00000455037 | |||||
PLA2G4F | ENST00000569985.5 | c.*1164A>G | 3_prime_UTR_variant, NMD_transcript_variant | 18/20 | 1 | ENSP00000454330 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151964Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000802 AC: 20AN: 249306Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134696
GnomAD3 exomes
AF:
AC:
20
AN:
249306
Hom.:
AF XY:
AC XY:
14
AN XY:
134696
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1458260Hom.: 0 Cov.: 31 AF XY: 0.0000483 AC XY: 35AN XY: 725160
GnomAD4 exome
AF:
AC:
50
AN:
1458260
Hom.:
Cov.:
31
AF XY:
AC XY:
35
AN XY:
725160
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74366
GnomAD4 genome
AF:
AC:
3
AN:
152084
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2021 | The c.2120A>G (p.Y707C) alteration is located in exon 18 (coding exon 18) of the PLA2G4F gene. This alteration results from a A to G substitution at nucleotide position 2120, causing the tyrosine (Y) at amino acid position 707 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
REVEL
Benign
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of phosphorylation at Y707 (P = 0.0666);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at